Hundreds of thousands of variants have been discovered. We know these variants affect cellular processes and play a part in complex diseases, but we don’t know how.
Variant to function (V2F) research focuses on mapping the variants we’ve found to disease, so we can discover new biomarkers, develop useful therapies, and make breakthroughs that will change how we treat complex diseases. Share your research and engage with other V2F researchers using #V2FNow.
Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79
View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ
View Illumina product videos
youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd
View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM